FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Fox News Campus Radicals Newsletter: UCLA mob mess, veiled threats of violence and a major win over DEI

NFL Legend and Hall of Famer Abruptly Hospitalized, Lawyer and Friend Issues Update

Trump Admin Throws Out Obama-Era Gender Rule in Favor of ‘What the Lord Established from the Beginning’

Florida Dem filed for re-election days before resignation as House Ethics Committee ramped up pressure

Poll Shows Young People Fleeing Major Dem City Due to Cost of Living, Safety, And Jobs

NANNY STATE: UK Slaps Nation’s Youth with Permanent Lifetime Smoking Ban

Grinning suspect cuffed after alleged fiery street takeover, drag race caught on camera

Texas substitute teacher accused of improper relationship with student, alarming parents

Incredible Video: Skycam Catches Massive Tornado Narrowly Missing Oklahoma Town During Violent Storm Outbreak

Trump Gives LA Mayor Karen Bass Special Copy of Bible During Oval Office Meeting

Mamdani in the hot seat after first veto derails bipartisan effort to combat antisemitism: ‘Disappointed’

Transgender lawmaker ‘doesn’t know what a woman is,’ White House says after dig at Trump firings

Hakeem Jeffries left scrambling after child reporter asks why voters view Democrats so negatively

Rob Reiner’s Oldest Son Speaks Out for First Time Since Parents’ Death: ‘Too Impossible to Process’

Israel Appoints Its First Ever ‘Special Envoy to Christian World’ After Controversial Incidents

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”